Summer Sale

Up to 30% off — ends 7 Aug

ONLY00h00m00s

Get 30% Off

Up to 30% off — ends 7 Aug

ONLY00h00m00s

Zanfina Ademi

MONASH UNIVERSITY

Australia

This profile is automatically generated from trusted academic sources.

Google Scholar

ORCID

How do I reach out?

Meet Kite AI

Contact this professor

ORCID

Google Scholar

Academic Page

Research Interests

Health Economics

90%

Cardiology

30%

Pharmacoeconomics

50%

Diabetology

30%

Hypercholesterolemia

20%

Economic Evaluation

20%

Cardiometabolic Health

20%

Ask ApplyKite AI

Start chatting

How can you help me contact this professor?

What are this professor's research interests?

How should I write an email to this professor?

Articles10

Considering equity and cost-effectiveness in assessing a parenting intervention to promote early childhood development in rural Vietnam

Article Link

Year:

2023

Cost-Effectiveness Analysis of Siltuximab for Australian Public Investment in the Rare Condition Idiopathic Multicentric Castleman Disease

Article Link

Year:

2023

Lipid-Lowering Strategies for Primary Prevention of Coronary Heart Disease in the UK: A Cost-Effectiveness Analysis

Article Link

Year:

2023

A Systematic Review of Cost-Effectiveness of Non-Statin Lipid-Lowering Drugs for Primary and Secondary Prevention of Cardiovascular Disease in Patients with Type 2 Diabetes Mellitus

Article Link

Year:

2023

Estimating Australian hospitalisation ratios and costs for wildtype SARS-CoV-2 in 2020

Article Link

Year:

2023

Projecting the Health and Economic Burden of Cardiovascular Disease Among People with Type 2 Diabetes, 2022–2031

Article Link

Year:

2023

Systematic Review of Cost-Effectiveness Analysis for Surgical and Neurostimulation Treatments for Drug-Resistant Epilepsy in Adults

Article Link

Year:

2023

Use of Decision-Analytic Modelling to Assess the Cost-Effectiveness of Diagnostic Imaging of the Spine, Shoulder, and Knee: A Scoping Review

Article Link

Year:

2023

Projecting the incidence and costs of major cardiovascular and kidney complications of type 2 diabetes with widespread SGLT2i and GLP-1 RA use: a cost-effectiveness analysis

Article Link

Year:

2023

Economic Evaluation of the Community Benefit of the Australian Pregnancy Register of Antiseizure Medications

Article Link

Year:

2023

Collaborators13

Jane Fisher

MONASH UNIVERSITY

AUSTRALIA

Jonathan Shaw

AUSTRALIA

David V Pilcher

MONASH UNIVERSITY

AUSTRALIA

Keith Abrams

Professor of Statistics & Data Science

University of Warwick

UNITED KINGDOM

Stanley Luchters

Professor in Population Health and Environment

Liverpool School of Tropical Medicine

UNITED KINGDOM

Daryl Jones

AUSTRALIA

Zhibin Chen

MONASH UNIVERSITY

AUSTRALIA

Kevan Polkinghorne

Prof

Monash Health

AUSTRALIA

Dianna Magliano

Lab Head/ Epidmiologist

Baker Heart and Diabetes Institute

AUSTRALIA

Clara Marquina

MONASH UNIVERSITY

AUSTRALIA

Rachelle Buchbinder

MONASH UNIVERSITY

AUSTRALIA

David Dunstan

Professor

Australian Catholic University

AUSTRALIA

Danny Liew

MONASH UNIVERSITY

AUSTRALIA

How do I reach out?

Meet Kite AI